Pharmaceuticals
-
A mother’s mission to help prevent another life lost to menb
Jun 29, 2016News Hour: One moment Patti Wukovits was preparing for her daughter’s high school graduation, and the next moment she was watching her fight for her life for 9 days in the intensive care unit. In 2012,... -
Advances body of evidence for tofacitinib citrate (xeljanz®) providing clinicians with additional information for the treatment of moderate to severe ra
Jun 29, 2016News Hour: Pfizer Inc. (NYSE:PFE) announced that 23 abstracts, including research and analyses for tofacitinib citrate (XELJANZ®), will be featured at the upcoming European League Against Rheumatism (EULAR) Congress (June 8-11, London). The research being shared... -
Fda advisory committees’ recommend alo-02 (oxycodone hydrochloride and naltrexone hydrochloride) extended-release capsules for approval
Jun 29, 2016News Hour: Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee voted (9 to 6) in favor... -
Pro golfer jim furyk teams up with pfizer to raise awareness for pneumococcal pneumonia and the importance of older adult vaccination
Jun 29, 2016News Hour: This Father’s Day, Jim Furyk will be thinking about more than just strategizing for the next Major as he joins Pfizer to encourage adults 65 and older to take responsibility for their health. On... -
Two pivotal phase 3 studies for ertugliflozin, an investigational sglt-2 inhibitor, met primary endpoints
Jun 29, 2016News Hour: Merck (NYSE:MRK), known as MSD outside the United States and Canada, in partnership with Pfizer Inc. (NYSE:PFE), announced that two Phase 3 studies (VERTIS Mono and VERTIS Factorial) of ertugliflozin, an investigational oral SGLT-2... -
Pfizer breaks ground on new biologics clinical manufacturing facility in andover, massachusetts
Jun 29, 2016News Hour: Pfizer Inc. broke ground for its new biologics clinical manufacturing facility in Andover, Massachusetts. Expanding the company’s presence in the state, Pfizer will invest more than $200 million in development of the 175,000 sq.... -
Help pfizer change the future of healthy aging
Jun 29, 2016News Hour: Pfizer Inc. is challenging people across the United States (U.S.) to develop the next big idea in healthy aging through a unique partnership with crowdfunding platform Indiegogo(link is external). As the first pharmaceutical company to... -
Pfizer invites public to view and listen to webcast of august 2 conference call with analysts
Jun 29, 2016News Hour: Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, August 2, 2016. The purpose of... -
Pfizer declares 30-cent third-quarter 2016 dividend
Jun 29, 2016News Hour: The board of directors of Pfizer Inc. declared a 30-cent third-quarter 2016 dividend on the company’s common stock, payable September 1, 2016, to shareholders of record at the close of business on August 5,... -
Pfizer completes acquisition of anacor
Jun 29, 2016News Hour: Pfizer Inc. (NYSE:PFE) announced that it has completed its acquisition of Anacor Pharmaceuticals, Inc. Under the terms of the transaction, each outstanding share of Anacor common stock has been converted into the right to...
